250 related articles for article (PubMed ID: 21986579)
1. Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
Zhou QM; Wang XF; Liu XJ; Zhang H; Lu YY; Su SB
Acta Pharmacol Sin; 2011 Nov; 32(11):1402-10. PubMed ID: 21986579
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.
Zhou QM; Chen QL; Du J; Wang XF; Lu YY; Zhang H; Su SB
Int J Mol Sci; 2014 Sep; 15(9):16284-301. PubMed ID: 25226537
[TBL] [Abstract][Full Text] [Related]
3. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
5. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner.
Choudhuri T; Pal S; Das T; Sa G
J Biol Chem; 2005 May; 280(20):20059-68. PubMed ID: 15738001
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
[TBL] [Abstract][Full Text] [Related]
8. Curcumin analog B14 has high bioavailability and enhances the effect of anti-breast cancer cells in vitro and in vivo.
Shen H; Shen J; Pan H; Xu L; Sheng H; Liu B; Yao M
Cancer Sci; 2021 Feb; 112(2):815-827. PubMed ID: 33316116
[TBL] [Abstract][Full Text] [Related]
9. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
Baharuddin P; Satar N; Fakiruddin KS; Zakaria N; Lim MN; Yusoff NM; Zakaria Z; Yahaya BH
Oncol Rep; 2016 Jan; 35(1):13-25. PubMed ID: 26531053
[TBL] [Abstract][Full Text] [Related]
10. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
11. Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1 and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines.
Ren L; Li Z; Dai C; Zhao D; Wang Y; Ma C; Liu C
Mol Med Rep; 2018 Mar; 17(3):4376-4382. PubMed ID: 29344652
[TBL] [Abstract][Full Text] [Related]
12. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines.
Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model.
Yu X; Luo Y; Zhou Y; Zhang Q; Wang J; Wei N; Mi M; Zhu J; Wang B; Chang H; Tang Y
Int J Oncol; 2008 Sep; 33(3):555-63. PubMed ID: 18695886
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.
Zhou Q; Ye M; Lu Y; Zhang H; Chen Q; Huang S; Su S
PLoS One; 2015; 10(8):e0136694. PubMed ID: 26305906
[TBL] [Abstract][Full Text] [Related]
15. Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells.
Ko JC; Tsai MS; Weng SH; Kuo YH; Chiu YF; Lin YW
Toxicol Appl Pharmacol; 2011 Sep; 255(3):327-38. PubMed ID: 21810436
[TBL] [Abstract][Full Text] [Related]
16. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
18. The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo.
Martin LA; Head JE; Pancholi S; Salter J; Quinn E; Detre S; Kaye S; Howes A; Dowsett M; Johnston SR
Mol Cancer Ther; 2007 Sep; 6(9):2458-67. PubMed ID: 17876043
[TBL] [Abstract][Full Text] [Related]
19. Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts.
Zhou QM; Zhang H; Lu YY; Wang XF; Su SB
Cancer Sci; 2009 Nov; 100(11):2040-5. PubMed ID: 19703194
[TBL] [Abstract][Full Text] [Related]
20. Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer.
Hashemzehi M; Behnam-Rassouli R; Hassanian SM; Moradi-Binabaj M; Moradi-Marjaneh R; Rahmani F; Fiuji H; Jamili M; Mirahmadi M; Boromand N; Piran M; Jafari M; Sahebkar A; Avan A; Khazaei M
J Cell Biochem; 2018 Jul; 119(7):5996-6007. PubMed ID: 29600521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
